ArticleCureus2026
Drug Inventory Management in a Pharmacy Store of a Tertiary Care Hospital Using Always Better Control (ABC) and Vital, Essential, and Desirable (VED) Analysis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEfficient drug inventory management ensures the uninterrupted availability of critical medicines while optimizing limited financial resources. Always Better Control (ABC) and Vital, Essential, and Desirable (VED) analyses are validated tools for identifying high-cost and high-priority items requiring strict oversight.
objectiveThis study aimed to analyze annual drug procurement expenditure using ABC, VED, and ABC-VED matrix methods in a tertiary care hospital from April 2018 to March 2019 and to identify priority medicines requiring enhanced managerial oversight to optimize inventory control and resource utilization.
methodsThis retrospective study evaluated all drugs purchased over one year. Drugs were categorized using ABC, VED, and ABC-VED matrix analyses (Categories I-III) to identify priority groups for managerial control. Category I comprised AV, AE, AD, BV, and CV items; Category II included BE, BD, and CE items; and Category III consisted solely of CD items.
resultsOverall, 1,402 drugs were procured during the study period, with an annual expenditure of ₹85,305,041.13. ABC analysis classified 135 items (9.62%) as Category A, 250 (17.83%) as Category B, and 1,017 (72.54%) as Category C, accounting for ₹59,813,194.80 (70.11%), ₹17,201,737.31 (20.16%), and ₹8,290,109.02 (9.72%) of total expenditure, respectively. VED analysis identified 373 items (26.60%) as vital, 613 (43.72%) as essential, and 416 (29.67%) as desirable, contributing ₹31,567,217.65 (37.00%), ₹39,230,038.25 (46.00%), and ₹14,507,785.23 (17.00%) of annual costs, respectively. Regarding the ABC-VED matrix, 458 items (32.66%) were classified as Category I, 624 (44.51%) as Category II, and 320 (22.82%) as Category III, accounting for ₹66,958,985.88 (78.49%), ₹15,745,645.07 (18.46%), and ₹2,600,410.18 (3.05%) of total expenditure, respectively.
conclusionThe ABC-VED matrix is a robust tool for identifying drugs requiring close monitoring and targeted cost-containment strategies while ensuring the continuous availability of vital and essential medicines in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.